Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer
{{output}}
Advanced epithelial cancers such as gastric, lung, and pancreatic tumors are featured by invasive proliferation, distant metastasis, acquired chemoresistance, and tumorigenic stemness. For the last decade, molecular-targeted therapies using therapeutic antibod... ...
